Aiforia

Aiforia Signs A Licensing Agreement With The Mayo Clinic For An AI Model That Improves Prediction Of Colorectal Cancer Recurrence

Aiforia has entered into an exclusive licensing agreement with the Mayo Clinic in the United States to globally commercialize an AI model that improves prediction of colorectal cancer recurrence. The ...

Aiforia Signs A Deal With An Italian Hospital In Catania

The Provincial Health Authority of Catania in Italy has selected Aiforia Technologies Plc as a partner for AI-assisted diagnostics in the anatomic pathology laboratory of Gravina Hospital. The colla...

Professor Inti Zlobec Joins Aiforia’s Scientific Advisory Board

Prof. Zlobec is a distinguished figure in the field of Digital Pathology, serving as Professor of Digital Pathology at the Institute of Tissue Medicine and Pathology, University of Bern in Switzerland...

Aiforia Has Received A Funding Decision From Business Finland To Accelerate The Development Of AI-assisted Software Solutions For Clinical Pathology And Drug Development

Aiforia has received a funding decision from Business Finland to accelerate the development of AI-assisted software solutions for clinical pathology and drug development. Aiforia Technologies Plc, Com...

First NHS Trust Has Signed A Contract To Adopt Aiforia PD-L1 AI Model For Lung Cancer In Clinical Diagnostics

The first NHS Trust of the PathLAKE Plus consortium has signed an individual contract to adopt Aiforia PD-L1 AI model for lung cancer in clinical diagnostics. The duration of the contract is three year...

Aiforia - Digital Pathology

Aiforia receives a contract award to provide AI solutions for 25 NHS hospitals of the PathLAKE Plus consortium in the UK

Aiforia Technologies Plc, Press Release, 10 February 2023 at 12:00 a.m. EEST. Aiforia has received a contract award to provide artificial intelligence solutions for 25 NHS Trusts pathology departments...

  • 1
  • 2